| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2090626 | C2CD2L | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.882 FDR=1 FC=-0.003 |
|
| 2090627 | C2CD2L | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=0.565 FDR=1 FC=0.005 |
|
| 2090628 | C2CD2L | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 11 | - |
PV=1 FDR=1 FC=0.003 |
|
| 2090629 | P2RX5 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 17 | - |
PV=0.13 FDR=1 FC=-0.039 |
